BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23943575)

  • 1. Surgical placement of totally implantable venous access device-an institutional experience.
    Chandrasekaran A; Somasundaram J
    Indian J Pediatr; 2014 Sep; 81(9):866-70. PubMed ID: 23943575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable venous access devices in children with severe hemophilia: a tertiary pediatric institutional experience.
    Bedoya MA; Raffini L; Durand R; Acord MR; Srinivasan A; Krishnamurthy G; Vatsky S; Escobar F; Cahill AM
    Pediatr Radiol; 2020 Jul; 50(8):1148-1155. PubMed ID: 32390060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radio-opacity and incidental identified mechanical complications of totally implantable venous access devices placed in the chest.
    Surov A; Rusner C; Weigand K; John E; Spielmann RP; Behrmann C
    Acta Radiol; 2012 Nov; 53(9):1035-9. PubMed ID: 23028172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Risk Factors for Totally Implantable Venous Access Device Infections in Pediatric Patients With Cancer: A Study of 25,954 Device-Days.
    Lee JK; Choi YB
    J Korean Med Sci; 2022 Sep; 37(35):e266. PubMed ID: 36065650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients.
    Kakkos A; Bresson L; Hudry D; Cousin S; Lervat C; Bogart E; Meurant JP; El Bedoui S; Decanter G; Hannebicque K; Regis C; Hamdani A; Penel N; Tresch-Bruneel E; Narducci F
    Eur J Surg Oncol; 2017 Apr; 43(4):689-695. PubMed ID: 27889197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the removal reasons of totally implantable venous devices in children: a retrospective study.
    Kılıç S; Soyer T; Karnak İ; Çiftçi AÖ; Tanyel FC; Şenocak ME
    Turk J Pediatr; 2016; 58(2):187-194. PubMed ID: 27976560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
    Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
    Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there any effect of first-day usage of a totally implantable venous access device on complications?
    Karanlik H; Odabas H; Yildirim I; Ozgur I; Kilic B; Sen F; Kurul S; Aydiner A
    Int J Clin Oncol; 2015 Dec; 20(6):1057-62. PubMed ID: 25911604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-guided totally implantable venous access device through the right innominate vein in older patients is safe and reliable.
    Sun X; Zhang Y; Yang C; Zhou Y; Bai X; Zheng W; Jin Y
    Geriatr Gerontol Int; 2019 Mar; 19(3):218-221. PubMed ID: 30724007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy.
    Kim JT; Oh TY; Chang WH; Jeong YK
    Med Oncol; 2012 Jun; 29(2):1361-4. PubMed ID: 21380779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems.
    Hartkamp A; van Boxtel AJ; Zonnenberg BA; Witteveen PO
    Neth J Med; 2000 Dec; 57(6):215-23. PubMed ID: 11099790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does systemic antibiotic prophylaxis prior to the placement of totally implantable venous access devices reduce early infection? A retrospective study of 1,485 cases at a large academic institution.
    Choksi A; Finnegan K; Etezadi V
    Am J Infect Control; 2020 Jan; 48(1):95-99. PubMed ID: 31439370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the time-to-removal of totally implantable venous access devices comparing valved-versus open-ended catheters in patients treated with chemotherapy.
    Amroun K; Brugel M; Rhaiem R; Teuma L; Vannieuwenhuyse G; Lipere A; Brenet E; Kianmanesh R; Bouché O
    J Vasc Access; 2024 Jan; ():11297298231223539. PubMed ID: 38205615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement.
    Liberale G; El Houkayem M; Viste C; Bouazza F; Moreau M; El Nakadi I; Veys I
    Support Care Cancer; 2016 Dec; 24(12):5035-5040. PubMed ID: 27495928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized study assessing different modalities for flushing totally implanted vascular access device in children with malignancy.
    Hsieh HC; Hung SC; Huang SY; Huang FL; Chou CM
    J Chin Med Assoc; 2022 Jan; 85(1):114-119. PubMed ID: 34407037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The catheter is stuck: complications experienced during removal of a totally implantable venous access device. A single-center study in 200 children.
    Wilson GJ; van Noesel MM; Hop WC; van de Ven C
    J Pediatr Surg; 2006 Oct; 41(10):1694-8. PubMed ID: 17011271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A totally implantable venous access device (TIVAD) abandoned for 5 years is re-accessed normally: A case report and literature review.
    He J
    J Vasc Access; 2023 May; 24(3):502-506. PubMed ID: 34396820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and late complications of totally implantable venous access devices.
    Grannan KJ; Taylor PH
    J Surg Oncol; 1990 May; 44(1):52-4. PubMed ID: 2111430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Totally Implantable Venous Access Device (Chemoport) in Oncology: Study of 168 Polyurethane Chemoport Catheter System.
    Mittal GS; Sundriyal D; Naik NB; Sehrawat A
    South Asian J Cancer; 2021 Dec; 10(4):261-264. PubMed ID: 34984207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.